Poly Medicure aims to double its international business by FY30, supported by a strong innovation pipeline and new manufacturing capacities, with plans to launch over 50 new products in critical care, cardiology, oncology, and vascular access. The company expects growth in both domestic and export markets, with a focus on emerging markets and local manufacturing to reduce costs.